Acadia Healthcare Company, Inc. (ACHC)
USD 39.05
(-1.49%)
USD 39.05
(-1.49%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 506.59 Million USD | 14.12% |
| 2022 | 443.9 Million USD | 7.1% |
| 2021 | 414.47 Million USD | 13.37% |
| 2020 | 365.6 Million USD | -9.62% |
| 2019 | 404.53 Million USD | -1.99% |
| 2018 | 412.74 Million USD | -5.74% |
| 2017 | 437.88 Million USD | -1.63% |
| 2016 | 445.14 Million USD | 38.76% |
| 2015 | 320.81 Million USD | 85.69% |
| 2014 | 172.76 Million USD | 40.46% |
| 2013 | 122.99 Million USD | 73.94% |
| 2012 | 70.71 Million USD | 343.28% |
| 2011 | -29.06 Million USD | -429.76% |
| 2010 | 8.81 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 147.19 Million USD | 3.15% |
| 2024 Q1 | 128.9 Million USD | 3.09% |
| 2024 Q2 | 142.71 Million USD | 10.71% |
| 2023 Q3 | 600.74 Million USD | 1.54% |
| 2023 Q4 | 125.04 Million USD | -79.19% |
| 2023 Q2 | 591.62 Million USD | 460.03% |
| 2023 FY | 506.59 Million USD | 14.12% |
| 2023 Q1 | 105.64 Million USD | -1.71% |
| 2022 Q3 | 115.1 Million USD | -8.81% |
| 2022 Q1 | 95.09 Million USD | -17.58% |
| 2022 Q4 | 107.47 Million USD | -6.63% |
| 2022 FY | 443.9 Million USD | 7.1% |
| 2022 Q2 | 126.22 Million USD | 32.73% |
| 2021 Q2 | 106.57 Million USD | 21.64% |
| 2021 Q4 | 115.38 Million USD | 9.76% |
| 2021 Q3 | 105.13 Million USD | -1.35% |
| 2021 Q1 | 87.61 Million USD | 128.11% |
| 2021 FY | 414.47 Million USD | 13.37% |
| 2020 Q1 | 86.19 Million USD | -13.47% |
| 2020 FY | 365.6 Million USD | -9.62% |
| 2020 Q2 | 79.09 Million USD | -8.23% |
| 2020 Q3 | 129.09 Million USD | 63.21% |
| 2020 Q4 | 38.4 Million USD | -70.25% |
| 2019 FY | 404.53 Million USD | -1.99% |
| 2019 Q2 | 113.62 Million USD | 27.21% |
| 2019 Q3 | 101.97 Million USD | -10.25% |
| 2019 Q4 | 99.6 Million USD | -2.33% |
| 2019 Q1 | 89.32 Million USD | -2.6% |
| 2018 FY | 412.74 Million USD | -5.74% |
| 2018 Q4 | 91.7 Million USD | -11.85% |
| 2018 Q3 | 104.04 Million USD | -11.8% |
| 2018 Q2 | 117.95 Million USD | 19.1% |
| 2018 Q1 | 99.03 Million USD | -11.02% |
| 2017 Q4 | 111.3 Million USD | -0.3% |
| 2017 Q1 | 95.36 Million USD | -11.87% |
| 2017 FY | 437.88 Million USD | -1.63% |
| 2017 Q2 | 119.58 Million USD | 25.4% |
| 2017 Q3 | 111.63 Million USD | -6.64% |
| 2016 FY | 445.14 Million USD | 38.76% |
| 2016 Q3 | 112.27 Million USD | -12.68% |
| 2016 Q1 | 96.08 Million USD | 10.03% |
| 2016 Q2 | 128.58 Million USD | 33.83% |
| 2016 Q4 | 108.2 Million USD | -3.63% |
| 2015 FY | 320.81 Million USD | 85.69% |
| 2015 Q4 | 87.32 Million USD | 1.24% |
| 2015 Q3 | 86.25 Million USD | 0.85% |
| 2015 Q2 | 85.52 Million USD | 38.58% |
| 2015 Q1 | 61.71 Million USD | 17.84% |
| 2014 Q4 | 52.37 Million USD | 0.84% |
| 2014 Q2 | 26.64 Million USD | -16.95% |
| 2014 Q3 | 51.93 Million USD | 94.93% |
| 2014 Q1 | 32.08 Million USD | -2.34% |
| 2014 FY | 172.76 Million USD | 40.46% |
| 2013 Q4 | 32.85 Million USD | 0.35% |
| 2013 Q1 | 26.31 Million USD | 13.43% |
| 2013 Q2 | 31.09 Million USD | 18.14% |
| 2013 FY | 122.99 Million USD | 73.94% |
| 2013 Q3 | 32.73 Million USD | 5.29% |
| 2012 Q2 | 10.02 Million USD | -18.64% |
| 2012 Q3 | 17.74 Million USD | 77.09% |
| 2012 Q1 | 12.31 Million USD | 167.03% |
| 2012 Q4 | 23.2 Million USD | 30.75% |
| 2012 FY | 70.71 Million USD | 343.28% |
| 2011 Q4 | -18.37 Million USD | -382.04% |
| 2011 Q2 | -18.94 Million USD | -6111.8% |
| 2011 FY | -29.06 Million USD | -429.76% |
| 2011 Q1 | -305 Thousand USD | -114.3% |
| 2011 Q3 | 6.51 Million USD | 134.38% |
| 2010 Q4 | 2.13 Million USD | 6.01% |
| 2010 Q3 | 2.01 Million USD | 0.0% |
| 2010 FY | 8.81 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Addus HomeCare Corporation | 90.95 Million USD | -456.968% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -5242.149% |
| Amedisys, Inc. | 156.39 Million USD | -223.923% |
| American Oncology Network, Inc. | -49.15 Million USD | 1130.63% |
| Astrana Health, Inc. | 84.61 Million USD | -498.721% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -6175.966% |
| IMAC Holdings, Inc. | -6.37 Million USD | 8045.971% |
| biote Corp. | 28.65 Million USD | -1667.791% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 4217.317% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | -349.457% |
| COMPASS Pathways plc | -136.91 Million USD | 469.997% |
| DocGo Inc. | 15.05 Million USD | -3264.973% |
| The Ensign Group, Inc. | 255.36 Million USD | -98.38% |
| Healthcare Services Group, Inc. | 62.35 Million USD | -712.399% |
| InnovAge Holding Corp. | -23.18 Million USD | 2285.487% |
| Assure Holdings Corp. | -20.08 Million USD | 2622.637% |
| The Joint Corp. | -2.07 Million USD | 24536.794% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 367.85% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 3325.957% |
| ModivCare Inc. | -139.94 Million USD | 461.994% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -1199170.868% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 6022.909% |
| Option Care Health, Inc. | 314.59 Million USD | -61.031% |
| P3 Health Partners Inc. | -167.86 Million USD | 401.797% |
| P3 Health Partners Inc. | -167.86 Million USD | 401.797% |
| The Pennant Group, Inc. | 25.16 Million USD | -1912.778% |
| Surgery Partners, Inc. | 328 Million USD | -54.45% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 17643.849% |
| Talkspace, Inc. | -23.2 Million USD | 2282.757% |
| Talkspace, Inc. | -23.2 Million USD | 2282.757% |
| The Oncology Institute, Inc. | -77.01 Million USD | 757.763% |
| The Oncology Institute, Inc. | -77.01 Million USD | 757.763% |